Clearside Biomedical files 1-for-15 reverse stock split, reduces authorized shares to 26.7M

Clearside Biomedical, Inc.

Reverse stock split effective September 12, 2025 at 5:00 p.m. ET; split-adjusted trading begins September 15, 2025.
Every 15 outstanding shares combine into 1; no fractional shares issued – cash in lieu.
Authorized common stock reduced from 400M to 26,666,666; par value unchanged at $0.001.
Proportionate adjustments to stock options, RSUs, warrants, and equity plan reserves.
New CUSIP 185063203; Nasdaq ticker CLSD unchanged.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.